SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023
20 7월 2023 - 5:09AM
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to
solving musculoskeletal disorders of the sacropelvic anatomy, today
announced that the company will be participating in the upcoming
2023 Canaccord Genuity 43rd Annual Growth Conference in Boston.
Management will be hosting a fireside chat on Wednesday, August
9th, 2023, at 12:00 p.m. Eastern Time / 9:00 a.m. Pacific Time.
Investors interested in listening to the conference call may do
so by registering at this link:
https://wsw.com/webcast/canaccord89/sibn/2458676. Live audio of the
webcast will be available on the “Investors” section of the
company’s website at: www.si-bone.com. The webcast will be archived
and available for replay for at least 90 days after the event.
About SI-BONE, Inc.SI-BONE (NASDAQ:
SIBN) is a global leader in technology for surgical treatment of
musculoskeletal disorders of the sacropelvic anatomy. Since
pioneering minimally invasive SI joint surgery in 2009, SI-BONE has
supported over 3,000 surgeons in performing a total of over 80,000
sacropelvic procedures. A unique body of clinical evidence supports
the use of SI-BONE’s technologies, including two randomized
controlled trials and over 120 peer reviewed publications.
SI-BONE has leveraged its leadership in minimally invasive SI
joint fusion to commercialize novel solutions for adjacent markets,
including adult deformity, spinopelvic fixation and pelvic
trauma.
For additional information on the company or the
products including risks and benefits, please
visit www.si-bone.com.
SI-BONE, iFuse Implant System and iFuse-TORQ are
registered trademarks of SI-BONE,
Inc. ©2023 SI-BONE, Inc. All Rights Reserved.
Investor Contact:Saqib IqbalSr.
Director, FP&A and Investor Relationsinvestors@SI-BONE.com
SI BONE (NASDAQ:SIBN)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
SI BONE (NASDAQ:SIBN)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024